loadpatents
name:-0.040560007095337
name:-0.024022817611694
name:-0.0071659088134766
SOREQ; Hermona Patent Filings

SOREQ; Hermona

Patent Applications and Registrations

Patent applications and USPTO patent grants for SOREQ; Hermona.The latest application filed is for "methods for controlling seizures by manipulating the levels of microrna-211 (mir-211) in the brain".

Company Profile
7.20.39
  • SOREQ; Hermona - Jerusalem IL
  • Soreq; Hermona - Jurusalem IL
  • Soreq; Hermona - Ein Kerem IL
  • Soreq; Hermona - Rishon le Zion IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
METHODS FOR CONTROLLING SEIZURES BY MANIPULATING THE LEVELS OF MICRORNA-211 (miR-211) IN THE BRAIN
App 20220098588 - BEKENSTEIN; Uriah ;   et al.
2022-03-31
Methods for controlling seizures by manipulating the levels of microRNA-211 (miR-211) in the brain
Grant 11,225,661 - Bekenstein , et al. January 18, 2
2022-01-18
Hybrid nanoparticles as photoinitiators
Grant 11,193,034 - Banin , et al. December 7, 2
2021-12-07
Methods for controlling seizures by manipulating the levels of microRNA-211 (miR-211) in the brain
App 20200102559 - Bekenstein; Uriah ;   et al.
2020-04-02
Hybrid Nanoparticles As Photoinitiators
App 20190390077 - BANIN; Uri ;   et al.
2019-12-26
Hybrid nanoparticles as photoinitiators
Grant 10,442,944 - Banin , et al. Oc
2019-10-15
Downregulating Mir-132 For The Treatment Of Lipid Related Disorders
App 20190078090 - SOREQ; Hermona ;   et al.
2019-03-14
Downregulating miR-132 for the treatment of lipid related disorders
Grant 10,174,320 - Soreq , et al. J
2019-01-08
Hybrid Nanoparticles As Photoinitiators
App 20180355200 - BANIN; Uri ;   et al.
2018-12-13
Downregulating Mir-132 For The Treatment Of Lipid Related Disorders
App 20170283800 - SOREQ; Hermona ;   et al.
2017-10-05
Clustered Single Nucleotide Polymorphisms In The Human Acetylcholinesterase Gene And Uses Thereof In Diagnosis And Therapy
App 20150119447 - Soreq; Hermona ;   et al.
2015-04-30
Antisense oligonucleotides against AChE in the treatment of gastrointestinal inflammation disorders
Grant 8,722,876 - Soreq , et al. May 13, 2
2014-05-13
Agents, Compositions And Methods For Treating Pathologies In Which Regulating An Ache-associated Biological Pathway Is Beneficial
App 20130317092 - SOREQ; HERMONA ;   et al.
2013-11-28
ANTISENSE OLIGONUCLEOTIDES AGAINST AchE IN THE TREATMENT OF GASTROINTESTINAL INFLAMMATION DISORDERS
App 20130310441 - Soreq; Hermona ;   et al.
2013-11-21
Method Of Treating Neurodegenerative Diseases
App 20130210901 - Soreq; Hermona ;   et al.
2013-08-15
Readthrough Acetylcholinesterase (ache-r) For Treating Or Preventing Parkinson's Disease
App 20130164288 - Soreq; Hermona ;   et al.
2013-06-27
AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT
App 20130018081 - Soreq; Hermona ;   et al.
2013-01-17
Agents, Compositions And Methods For Treating Pathologies In Which Regulating An Ache-associated Biological Pathway Is Beneficial
App 20120295963 - SOREQ; HERMONA ;   et al.
2012-11-22
Toll-like Receptor 9 Agonists For The Treatment Of Anxiety-related Disorders And Inflammatory Disorders
App 20110136897 - Soreq; Hermona ;   et al.
2011-06-09
Materials And Methods For Treating Or Preventing Organophosphate Exposure Associated Damage
App 20110064716 - Soreq; Hermona ;   et al.
2011-03-17
Acetylcholinesterase (ache)-derived Peptide As An Inducer Of Granulocytopoiesis, Uses And Methods Thereof
App 20110039791 - Soreq; Hermona ;   et al.
2011-02-17
Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof
Grant 7,838,493 - Soreq , et al. November 23, 2
2010-11-23
Acetylcholinesterase (AChE) variants of the N-terminus
App 20100279381 - Soreq; Hermona ;   et al.
2010-11-04
Agents, Compositions And Methods For Treating Pathologies In Which Regulating An Ache-associated Biological Pathway Is Beneficial
App 20100216868 - Soreq; Hermona ;   et al.
2010-08-26
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
App 20090281165 - Soreq; Hermona ;   et al.
2009-11-12
Compounds, Pharmaceutical Compositions and Therapeutic Methods of Preventing and Treating Diseases and Disorders Associated With Amyloid Fibril Formation
App 20090169520 - Soreq; Hermona ;   et al.
2009-07-02
Method for assessing trait anxiety by determining cholinergic status
Grant 7,494,783 - Soreq , et al. February 24, 2
2009-02-24
AChE antisense oligonucleotide as an anti-inflammatory agent
App 20090005331 - Soreq; Hermona ;   et al.
2009-01-01
Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
App 20080306014 - Soreq; Hermona ;   et al.
2008-12-11
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
Grant 7,456,154 - Soreq , et al. November 25, 2
2008-11-25
Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
App 20070293452 - Soreq; Hermona ;   et al.
2007-12-20
Arp as an Inducer of Granulocytopoiesis, Uses and Methods Thereof
App 20070224181 - Soreq; Hermona ;   et al.
2007-09-27
Acetylcholinesterase-derived peptides and uses thereof
App 20070065882 - Soreq; Hermona ;   et al.
2007-03-22
Method and kit for assessing anxiety or disposition thereto in a subject
App 20070037241 - Soreq; Hermona ;   et al.
2007-02-15
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
App 20060178333 - Soreq; Hermona ;   et al.
2006-08-10
Parkinson's disease susceptibility haptotype as a tool for genetic screening
App 20060166204 - Soreq; Hermona ;   et al.
2006-07-27
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
Grant 7,074,915 - Soreq , et al. July 11, 2
2006-07-11
Acetylcholinesterase-derived peptides and uses thereof
Grant 7,067,486 - Soreq , et al. June 27, 2
2006-06-27
Uses of antibodies against AChE and peptides thereof
Grant 7,063,948 - Soreq , et al. June 20, 2
2006-06-20
Novel uses of antibodies against AChE and peptides thereof
App 20060121536 - Soreq; Hermona ;   et al.
2006-06-08
AChE antisense oligonucleotide as an anti-inflammatory agent
App 20060069051 - Soreq; Hermona ;   et al.
2006-03-30
Transgenic non-human mammals producing a cholinesterase in their milk
Grant 6,987,211 - Soreq , et al. January 17, 2
2006-01-17
Expression of recombinant human acetylcholinesterase in transgenic plants
Grant 6,770,799 - Mor , et al. August 3, 2
2004-08-03
Expression of recombinant human acetylcholinesterase in transgenic plants
App 20040148657 - Mor, Tsafrir S. ;   et al.
2004-07-29
Hybrid transgenic mouse with accelerated onsent of Alzheimer type amyloid plaques in brain
App 20040016008 - Brimijoin, William Stephen ;   et al.
2004-01-22
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
App 20030216344 - Soreq, Hermona ;   et al.
2003-11-20
Acetylcholinesterase-derived peptides and uses thereof
App 20030036632 - Soreq, Hermona ;   et al.
2003-02-20
Methods and compositions for the treatment of injury to the central nervous system
Grant 6,475,998 - Soreq , et al. November 5, 2
2002-11-05
Expression of recombinant human acetylcholinesterase in transgenic plants
App 20020162140 - Mor, Tsafrir S. ;   et al.
2002-10-31
Synthetic antisense oligodeoxynucleotides targeted to human ache
Grant 6,121,046 - Soreq , et al. September 19, 2
2000-09-19
Synthetic antisense oligodeoxynucleotides targeted to AChE
Grant 6,110,742 - Soreq , et al. August 29, 2
2000-08-29
Transgenic animal assay system for anti-cholinesterase substances
Grant 6,025,183 - Soreq , et al. February 15, 2
2000-02-15
Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
Grant 5,891,725 - Soreq , et al. April 6, 1
1999-04-06
Genetically engineered human acetylcholinesterase
Grant 5,595,903 - Soreq , et al. January 21, 1
1997-01-21
Human cholinesterase genes
Grant 5,215,909 - Soreq June 1, 1
1993-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed